19,549 Shares in The Cooper Companies, Inc. $COO Bought by Bank of Nova Scotia

Bank of Nova Scotia bought a new position in shares of The Cooper Companies, Inc. (NASDAQ:COO) in the 2nd quarter, HoldingsChannel.com reports. The firm bought 19,549 shares of the medical device company’s stock, valued at approximately $1,402,000.

A number of other institutional investors have also added to or reduced their stakes in the business. Elevation Point Wealth Partners LLC purchased a new position in shares of Cooper Companies during the second quarter worth about $921,000. Commerce Bank purchased a new stake in Cooper Companies in the second quarter valued at approximately $6,469,000. Northwestern Mutual Wealth Management Co. purchased a new position in Cooper Companies in the 2nd quarter worth approximately $60,000. Evolve Private Wealth LLC purchased a new position in Cooper Companies in the 2nd quarter worth approximately $648,000. Finally, Findlay Park Partners LLP bought a new position in shares of Cooper Companies in the 2nd quarter worth $92,076,000. 24.39% of the stock is currently owned by institutional investors.

Wall Street Analysts Forecast Growth

Several research analysts recently issued reports on the stock. Weiss Ratings lowered shares of Cooper Companies from a “hold (c-)” rating to a “sell (d)” rating in a research report on Monday, June 8th. Piper Sandler set a $86.00 target price on Cooper Companies and gave the stock an “overweight” rating in a research report on Monday, June 1st. Citigroup restated a “neutral” rating and set a $80.00 price target (up from $76.00) on shares of Cooper Companies in a research report on Thursday, August 13th. Wall Street Zen raised shares of Cooper Companies from a “hold” rating to a “buy” rating in a research note on Sunday, June 21st. Finally, Mizuho set a $85.00 price target on Cooper Companies and gave the company an “outperform” rating in a report on Thursday, June 4th. One analyst has rated the stock with a Strong Buy rating, seven have assigned a Buy rating, six have issued a Hold rating and three have assigned a Sell rating to the company. Based on data from MarketBeat.com, Cooper Companies currently has an average rating of “Hold” and an average price target of $81.64.

Cooper Companies Stock Down 0.5%

Shares of Cooper Companies stock opened at $72.68 on Thursday. The company has a current ratio of 1.27, a quick ratio of 0.78 and a debt-to-equity ratio of 0.23. The Cooper Companies, Inc. has a 12-month low of $58.89 and a 12-month high of $89.83. The company has a market cap of $14.17 billion, a P/E ratio of 61.59, a PEG ratio of 1.91 and a beta of 0.83. The company’s fifty day simple moving average is $72.36 and its two-hundred day simple moving average is $70.96.

Cooper Companies (NASDAQ:COO) last posted its earnings results on Thursday, June 4th. The medical device company reported $1.21 EPS for the quarter, topping the consensus estimate of $1.10 by $0.11. Cooper Companies had a net margin of 5.57% and a return on equity of 10.88%. The firm had revenue of $1.08 billion during the quarter, compared to analysts’ expectations of $1.05 billion. During the same period last year, the company posted $0.96 EPS. The company’s quarterly revenue was up 7.9% compared to the same quarter last year. Cooper Companies has set its FY 2026 guidance at 4.580-4.660 EPS. Research analysts anticipate that The Cooper Companies, Inc. will post 4.63 EPS for the current year.

Cooper Companies Profile

Cooper Companies, Inc (NASDAQ: COO) is a global medical device company headquartered in San Ramon, California. Founded in 1958, the company has grown through strategic acquisitions and organic development to become a major provider of vision care and women’s health products. Cooper Companies operates through two primary business segments—CooperVision and CooperSurgical—each serving specialized markets within the healthcare industry.

The CooperVision segment develops, manufactures and markets a broad range of soft contact lenses, as well as related accessories.